ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "African-Americans"

  • Abstract Number: 583 • 2016 ACR/ARHP Annual Meeting

    Associations of Serum Anti-Citrullinated Proteins and Cytokines with Radiographic Scores in African-American Rheumatoid Arthritis Patients

    Dongmei Sun1, William H Robinson2, Xiangqin Cui3, Vincent A. Laufer4, Maria I. Danila5, Richard J. Reynolds6, Chander Raman7, Stephanie Ledbetter8, Alexander Szalai9 and S. Louis Bridges Jr.9, 1Department of Medicine, University of Alabama at Birmingham, Birmingham, AL, 2Division of Immunology and Rheumatology, Stanford University School of Medicine, Stanford, CA, 3Biostatistics, University of Alabama at Birmingham, Birmingham, AL, 4Division of Clinical Rheumatology and Immunology, University of Alabama at Birmingham, Birmingham, AL, 5University of Alabama at Birmingham, Birmingham, AL, 6Medicine, University of Alabama at Birmingham, Birmingham, AL, 7Medicine/Division of Clinical Immunology and Rheumatology, University of Alabama at Birmingham, Birmingham, AL, 81825 University Blvd., University of Alabama at Birmingham, Birmingham, AL, 9Rheumatology, University of Alabama at Birmingham, Birmingham, AL

    Background/Purpose: Serum anti-citrullinated proteins (ACPA, including anti-CCP antibodies) and rheumatoid factor (RF) are critical diagnostic markers for RA, and are associated with more severe radiographic…
  • Abstract Number: 780 • 2016 ACR/ARHP Annual Meeting

    Belimumab Use in African-American Patients in an U.S. Academic Medical Center

    Paloma Alejandro1, Anjani Pillarisetty2 and Christopher E. Collins3, 1Rheumatology, MedStar Washington Hospital Center/Georgetown University Medical Center, Washington, DC, 2Internal Medicine, MedStar Washington Hospital Center/Georgetown University Medical Center, Washington, DC, 3MedStar Washington Hospital Center/Georgetown University Medical Center, Washington, DC

    Background/Purpose: Belimumab is an anti-BAFF monoclonal antibody approved for the treatment of auto-antibody positive patients with SLE. In two large phase 3 clinical trials, belimumab…
  • Abstract Number: 1969 • 2016 ACR/ARHP Annual Meeting

    Peer Approaches to Lupus Self-Management (PALS): A Novel Lupus Peer Mentorship Intervention

    Edith M. Williams1, Leonard Egede2, Jim Oates3, Delia Voronca2 and Mulugeta Gebregziabher2, 1Public Health Sciences, Medical University of South Carolina, Charleston, SC, 2Medical University of South Carolina, Charleston, SC, 3Medicine/Rheumatology & Immunology, Medical University of South Carolina, Charleston, SC

    Background/Purpose: Systemic Lupus Erythematosus (SLE) is a chronic autoimmune disease that is associated with increased morbidity, mortality, health care costs and decreased quality of life.…
  • Abstract Number: 2351 • 2016 ACR/ARHP Annual Meeting

    Racial Differences in Magnetic Resonance Image-Based Three-Dimensional Bone Shape of the Knee: Data from the Osteoarthritis Initiative (OAI)

    Jing-Sheng Li1, Michael A Bowes2, David T. Felson3, Philip G. Conaghan4, Carrie Brown5 and Tuhina Neogi6, 1Boston University, Boston, MA, 2Imorphics Ltd, Manchester, United Kingdom, 3Clinical Epidemiology Unit, Boston University School of Medicine, Boston, MA, 4Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, Leeds, United Kingdom, 5Boston University School of Public Health, Boston, MA, 6Clinical Epidemiology, Boston University School of Medicine, Boston, MA

    Background/Purpose:  African Americans have higher prevalence and greater severity of knee osteoarthritis (OA) on radiographs compared with Caucasians. Magnetic resonance imaging (MRI)-based quantification of 3-dimensional…
  • Abstract Number: 3103 • 2016 ACR/ARHP Annual Meeting

    Apolipoprotein L1 Risk Variants Associate with Prevalent Cardiovascular Disease in African American Systemic Lupus Erythematous Patients

    Ashira Blazer1, Robert M Clancy2, H. Michael Belmont3, Peter M. Izmirly3, Androo Markham4 and Jill P. Buyon4, 1Division of Rheumatology, NYU School of Medicine, New York, NY, 2Department of Medicine, Division of Rheumatology, New York University School of Medicine, New York, NY, 3New York University School of Medicine, New York, NY, 4Medicine, New York University School of Medicine, New York, NY

    Background/Purpose:  Two Apolipoprotein L1 (APOL1) risk variants (RV), G1 and G2, located on chromosome 22q12.3, have been associated with excess renal risk in African Americans…
  • Abstract Number: 88 • 2015 ACR/ARHP Annual Meeting

    Integrating Evidence for Genetic Association and Natural Selection Helps Detect New Systemic Lupus Erythematosus Risk Loci in African-Americans

    Paula S. Ramos1, Satria Sajuthi2, Jasmin Divers3, Kenneth M. Kaufman4, Uma Nayak5, Wei-Min Chen5, Kelly J. Hunt6, Diane L. Kamen7, Gary S. Gilkeson8, Jyotika K. Fernandes7, Ida J. Spruill9, Robert P. Kimberly10, John B. Harley11, W. Timothy Garvey12, Michèle M. Sale13 and Carl D. Langefeld2, 1Department of Medicine, Medical University of South Carolina, Charleston, SC, 2Biostatistical Sciences, Wake Forest School of Medicine, Winston-Salem, NC, 3Department of Biostatistical Sciences, Wake Forest School of Medicine, Winston-Salem, NC, 4Center for Autoimmune Genomics and Etiology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, 5Public Health Sciences, University of Virginia, Charlottesville, VA, 6Public Health Sciences, Medical University of South Carolina, Charleston, SC, 7Medicine, Medical University of South Carolina, Charleston, SC, 8Department of Medicine, Division of Rheumatology, Medical University of South Carolina, Charleston, SC, 9Nursing, Medical University of South Carolina, Charleston, SC, 10Medicine, Clinical Immun & Rheumatology, University of Alabama at Birmingham, Birmingham, AL, 11Center for Autoimmune Genomics and Etiology (CAGE), Cincinnati Children's Hospital Medical Center, Cincinnati, OH, 12Department of Nutrition Sciences and Birmingham VA Medical Center, University of Alabama at Birmingham, Birmingham, AL, 13Department of Medicine and Center for Public Health Genomics, University of Virginia, Charlottesville, VA

    Background/Purpose: In many rheumatologic and autoimmune diseases African Americans (AA) have a higher prevalence and greater disease severity than other ethnicities. We posit that population-specific…
  • Abstract Number: 390 • 2015 ACR/ARHP Annual Meeting

    Treatment and Outcomes in Pediatric SLE Patients in South Africa

    Laura Lewandowski1, Christiaan Scott2, Laura Schanberg3 and Nathan Thielman4, 1Pediatric Rheumatology, Duke University Medical Center, Durham, NC, 2Rheumatology, Red Cross War Memorial Children's Hospital, Cape Town, South Africa, 3Duke University, Durham, NC, 4Duke Hubert Yeargan Center for Global Health, Durham, NC

    Background/Purpose:   Although African children with SLE may be at high risk for poor outcomes based on race, socioeconomic status, and age, little research has…
  • Abstract Number: 715 • 2015 ACR/ARHP Annual Meeting

    Investigating the Role of Vitamin D in Patients with SLE

    Briana K. Ply1 and Diane L. Kamen2, 1Medical University of South Carolina, Charleston, SC, 2Medicine, Medical University of South Carolina, Charleston, SC

    Background/Purpose: Vitamin D is a steroid hormone that not only functions in maintaining calcium and bone metabolism, but also displays immunoregulatory and anti-inflammatory properties. Recent…
  • Abstract Number: 790 • 2015 ACR/ARHP Annual Meeting

    An Intervention to Improve Quality of Life for African-American Lupus Patients

    Edith M. Williams1, Johnese Bostic2, Alyssa Adkins3, Larisa Bruner2, Jiajia Zhang2, Diane L. Kamen4 and Jim Oates4, 1Institute for Partnerships to Eliminate Health Disparities, University of South Carolina, Columbia, SC, 2University of South Carolina, Columbia, SC, 3University of South Carolina, Greenville, SC, 4Medicine, Medical University of South Carolina, Charleston, SC

    Background/Purpose: The Intervention to Improve Quality of life for African-AmericaN lupus patients (IQAN) Project is designed to examine whether a uniquely tailored intervention program can…
  • Abstract Number: 808 • 2015 ACR/ARHP Annual Meeting

    Heritable Endotheliopathy and ApolipoproteinL1 Risk Traits in SLE

    Ashira Blazer1, Andrew Markham2, Sara Rasmussen3, Jill P. Buyon4, H. Michael Belmont5, Shilpi Mehta-Lee6, Janet Nwaukoni4, Peter M. Izmirly7 and Robert Clancy4, 1Division of Rheumatology, NYU School of Medicine, New York, NY, 2Medicine, New York University School of Medicine, New York, NY, 3Department of Medicine, Division of Rheumatology, New York University School of Medicine, New York, NY, 4Medicine, Division of Rheumatology, New York University School of Medicine, New York, NY, 5Hosp for Joint Disease, New York, NY, 6Obstetrics and Gynecology, New York University School of Medicine, New York, NY, 7Rheumatology, NYU School of Medicine, New York, NY

    Background/Purpose: With higher prevalence of renal and cardiovascular diseases (CVD), as well as HTN, African American (AA) SLE patients experience accelerated damage accrual and excess…
  • Abstract Number: 1004 • 2015 ACR/ARHP Annual Meeting

    Prevalence and Cross-Sectional Risk Factors of Ankle Osteoarthritis in a Community-Based Cohort

    Shahmeer Lateef1, Yvonne M. Golightly2, Jordan B. Renner3, Joanne M. Jordan1 and Amanda E. Nelson1, 1Thurston Arthritis Research Center, University of North Carolina, Chapel Hill, NC, 2Epidemiology, University of North Carolina, Chapel Hill, NC, 3Radiology, University of North Carolina, Chapel Hill, NC

    Background/Purpose: Historically, ankle osteoarthritis (OA) has been considered uncommon, and its development has been thought of as a consequence of primarily ankle injury. Other etiologies…
  • Abstract Number: 2066 • 2015 ACR/ARHP Annual Meeting

    Elevated Innate, Adaptive, and TNF-Superfamily Soluble Inflammatory Mediators Mark Impending Disease Flare, While Regulatory Mediators Distinguish Lack of Impending Disease Flare in African-American SLE Patients with Active Disease

    Melissa E. Munroe1, Evan G. Vista2, Joan T. Merrill3, Joel M. Guthridge1, Virginia C. Roberts1 and Judith A. James4, 1Arthritis and Clinical Immunology, Oklahoma Medical Research Foundation, Oklahoma City, OK, 2Rheumatology and Clinical Immunology, University of Santo Tomas, Taguig City, Philippines, 3Clinical Pharmacology, Oklahoma Medical Research Foundation, Oklahoma City, OK, 4Arthritis and Clinical Immunology, University of Oklahoma Health Sciences Center and Oklahoma Medical Research Foundation, Oklahoma City, OK

    Background/Purpose: SLE is a multifaceted disease characterized by immune dysregulation and varied disease activity. Identifying mechanistic mediators of altered disease activity would help prevent damage…
  • Abstract Number: 1333 • 2014 ACR/ARHP Annual Meeting

    Bridging the Social Support Needs Gap for African American Women with Systemic Lupus Erythematosus through the Chronic Disease Self-Management Program

    Charmayne M. Dunlop-Thomas1, Hannah Cooper2, Terrika Barham3 and Cristina M. Drenkard4, 1Medicine Rheumatology, Emory University, Atlanta, GA, 2Rollins School of Public Health: Behavioral Sciences & Health, Emory Unversity, Atlanta, GA, 3Emory University, Atlanta, GA, 4Medicine, Div Rheumatology, Emory University, Atlanta, GA

    Background/Purpose:   Social support is instrumental in the mental and physical well-being of people with systemic lupus erythematosus (SLE).  Research has demonstrated that strengthening social…
  • Abstract Number: 2956 • 2014 ACR/ARHP Annual Meeting

    Identification of Autoimmune Functional Variants Under Positive Selection in the Gullah African American Population of South Carolina

    Paula S. Ramos1, Satria Sajuthi2, Jasmin Divers2, Yiqi Huang3, Uma Nayak4, Wei-Min Chen4, Kelly J. Hunt5, Diane L. Kamen6, Gary S. Gilkeson6, Jyotika K. Fernandes7, Ida J. Spruill7, W. Timothy Garvey8, Michèle M. Sale3 and Carl D. Langefeld2, 1Department of Medicine, Medical University of South Carolina, Charleston, SC, 2Department of Biostatistical Sciences, Wake Forest School of Medicine, Winston-Salem, NC, 3Department of Medicine and Center for Public Health Genomics, University of Virginia, Charlottesville, VA, 4Public Health Sciences, University of Virginia, Charlottesville, VA, 5Public Health Sciences, Medical University of South Carolina, Charleston, SC, 6Department of Medicine, Division of Rheumatology, Medical University of South Carolina, Charleston, SC, 7Medical University of South Carolina, Charleston, SC, 8Department of Nutrition Sciences and Birmingham VA Medical Center, University of Alabama at Birmingham, Birmingham, AL

    Background/Purpose The reasons for the ethnic disparities in rheumatologic and autoimmune diseases (ADs) are largely unknown. We posit that population-specific selection influencing the allele frequencies…
  • Abstract Number: 2688 • 2014 ACR/ARHP Annual Meeting

    Comparison of Systemic Lupus Erythematosus and Healthy Anti-Nuclear Antibody Positive African-Americans Reveals Distinct Differences in T Cell and Progenitor Populations

    Rufei Lu1,2, Samantha Slight-Webb1, Holden T. Maecker3, Paul J. Utz4, Joel M. Guthridge1 and Judith A. James5,6, 1Arthritis and Clinical Immunology, Oklahoma Medical Research Foundation, Oklahoma City, OK, 2Medicine and Pathology, University of Oklahoma Health Sciences Center, Oklahoma City, OK, 3Division of Immunology and Rheumatology, Stanford University School of Medicine, Stanford, CA, 4Medicine, Stanford University School of Medicine, Stanford, CA, 5Clinical Arthritis and Immunology, Oklahoma Medical Research Foundation, Oklahoma City, OK, 6Rheumatology, University of Oklahoma Health Sciences Center, Oklahoma City, OK

    Background/Purpose Systemic lupus erythematosus (SLE) is a systemic autoimmune disorder which arises from both genetic and environmental factors that likely affect phenotypic and functional characteristics…
  • « Previous Page
  • 1
  • 2
  • 3
  • 4
  • 5
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology